LON:FPEO F&C Private Equity Trust (FPEO) Share Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free FPEO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume41,927 shsAverage Volume62,649 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get F&C Private Equity Trust alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About F&C Private Equity TrustF&C Private Equity Trust plc specializes in secondary indirect, direct and investing in other funds. Within investing in other funds, the fund specializes in private equity funds, offshore funds, buy-out funds, venture funds, mezzanine funds, and investment trusts. Within the direct investment, it invests in mezzanine, early venture, mid venture, late venture, middle market, later stage, mature and buyout. The fund seeks that at the time of investment, no more than 15 per cent of total assets may be invested in United Kingdom listed investment companies, no more than 15 per cent of total assets may be invested in non-UK listed investment companies, no more than 33 per cent of total assets may be invested in direct private equity co-investments, and no more than 10 per cent of total assets may be invested outside the United States of America, the United Kingdom, and Continental Europe. It primarily has a global remit but a United Kingdom and European mid-market bias. The fund primarily invests in the stocks of mid-cap companies, and invests in emerging markets.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> FPEO Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive FPEO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for F&C Private Equity Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinance Industry Asset Management Sub-IndustryN/A Current SymbolLON:FPEO CUSIPN/A CIKN/A Webwww.fandc.com Phone+44-20-76288000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Hamish MairDirector, Head of Private Equity and Lead Mang.Mr. Neil SneddonDeputy Fund Mang.Key Competitors(DP3D.L)LON:DP3DAmedeo ResourcesLON:AMEDCandover InvestmentsLON:CDIDowning Two VCT PLC Closed-Ended FundLON:DP2DDunedin Smaller Companies Investment TrustLON:DNDLView All Competitors FPEO Stock Analysis - Frequently Asked Questions What other stocks do shareholders of F&C Private Equity Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other F&C Private Equity Trust investors own include Sirius Minerals (SXX), ICG Enterprise Trust (ICGT), F&C Global Smaller Companies (FCS) and European Assets Trust (EAT). This page (LON:FPEO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F&C Private Equity Trust Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.